Nasopharyngeal carcinoma epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
mNo edit summary
m (Bot: Removing from Primary care)
 
(41 intermediate revisions by 7 users not shown)
Line 1: Line 1:
{{CMG}}
__NOTOC__
{{Nasopharyngeal carcinoma}}
{{Nasopharyngeal carcinoma}}
{{CMG}} {{AE}}{{Homa}}{{Faizan}}
==Overview==
The [[incidence]] of nasopharyngeal carcinoma is different based on the geographic areas. The [[incidence]] in the [[USA]] is low, in Alaska and Greenland is moderate and the highest [[incidence]] is seen in southeast Asia, North Africa, southern China and middle east. The [[incidence]] of this [[disease]] increases with increasing age in low- risk [[population]]. However, in high-risk [[Population|populations]], the maximum [[incidence]] is seen in individuals around ages 50 to 59 and then the [[incidence]] decreases by increasing age. Nasopharyngeal carcinoma usually affects individuals of the Asian [[race]], and is more commonly affected by [[male]] than [[female]]. The majority of nasopharyngeal carcinoma cases are reported in southern China, Southeast Asia, North Africa and also is more seen in Inuit Indians.
==Epidemiology and Demographics==
===Incidence===
*The [[incidence]] of nasopharyngeal carcinoma is different based on the [[geographic]] areas. The [[incidence]] in the [[USA]] is approximately 0.2 to 0.5 per 100,000 [[individuals]], in Alaska and Greenland is 15 to 20 per 100,000 individuals and the highest [[incidence]] is seen in southeast Asia, North Africa, southern China and middle east with the [[incidence]] of 80 per 100,000 individuals.<ref name="CaponigroLongo2010">{{cite journal|last1=Caponigro|first1=Francesco|last2=Longo|first2=Francesco|last3=Ionna|first3=Franco|last4=Perri|first4=Francesco|title=Treatment approaches to nasopharyngeal carcinoma: a review|journal=Anti-Cancer Drugs|volume=21|issue=5|year=2010|pages=471–477|issn=0959-4973|doi=10.1097/CAD.0b013e328337160e}}</ref><ref name="LeeNg2012">{{cite journal|last1=Lee|first1=Anne W.M.|last2=Ng|first2=W.T.|last3=Chan|first3=Y.H.|last4=Sze|first4=Henry|last5=Chan|first5=Connie|last6=Lam|first6=T.H.|title=The battle against nasopharyngeal cancer|journal=Radiotherapy and Oncology|volume=104|issue=3|year=2012|pages=272–278|issn=01678140|doi=10.1016/j.radonc.2012.08.001}}</ref>
===Case-fatality rate/Mortality rate===
*In 2008 , the [[incidence]] of nasopharyngeal carcinoma is approximately 0.84 per 100,000 individuals with [[mortality rate]] of 61.13%.<ref name="JemalBray2011">{{cite journal|last1=Jemal|first1=Ahmedin|last2=Bray|first2=Freddie|last3=Center|first3=Melissa M.|last4=Ferlay|first4=Jacques|last5=Ward|first5=Elizabeth|last6=Forman|first6=David|title=Global cancer statistics|journal=CA: A Cancer Journal for Clinicians|volume=61|issue=2|year=2011|pages=69–90|issn=00079235|doi=10.3322/caac.20107}}</ref>


==Overview==
===Age===
*The [[incidence]] of nasopharyngeal carcinoma increases with increasing age in low- risk [[population]]. However, in high-risk [[Population|populations]], the maximum [[incidence]] is seen in individuals around ages 50 to 59 and then the [[incidence]] decreases by increasing age.<ref name="LeeKo2016">{{cite journal|last1=Lee|first1=Jivianne T.|last2=Ko|first2=Clifford Y.|title=Has survival improved for nasopharyngeal carcinoma in the United States?|journal=Otolaryngology-Head and Neck Surgery|volume=132|issue=2|year=2016|pages=303–308|issn=0194-5998|doi=10.1016/j.otohns.2004.09.018}}</ref><ref name="LeeFoo2003">{{cite journal|last1=Lee|first1=Anne W.M.|last2=Foo|first2=William|last3=Mang|first3=Oscar|last4=Sze|first4=W.M.|last5=Chappell|first5=Rick|last6=Lau|first6=W.H.|last7=Ko|first7=W.M.|title=Changing epidemiology of nasopharyngeal carcinoma in Hong Kong over a 20-year period (1980-99): An encouraging reduction in both incidence and mortality|journal=International Journal of Cancer|volume=103|issue=5|year=2003|pages=680–685|issn=0020-7136|doi=10.1002/ijc.10894}}</ref>
 
===Race===
*Nasopharyngeal carcinoma usually affects individuals of the Asian [[race]].<ref name="WangZhang2013">{{cite journal|last1=Wang|first1=Yu|last2=Zhang|first2=Yawei|last3=Ma|first3=Shuangge|title=Racial differences in nasopharyngeal carcinoma in the United States|journal=Cancer Epidemiology|volume=37|issue=6|year=2013|pages=793–802|issn=18777821|doi=10.1016/j.canep.2013.08.008}}</ref>
 
===Gender===
*Nasopharyngeal carcinoma is more commonly affected by [[male]] than [[female]]. The [[male]] to [[female]] [[ratio]] is approximately 2-3 to 1.<ref name="JiaQin2012">{{cite journal|last1=Jia|first1=Wei-Hua|last2=Qin|first2=Hai-De|title=Non-viral environmental risk factors for nasopharyngeal carcinoma: A systematic review|journal=Seminars in Cancer Biology|volume=22|issue=2|year=2012|pages=117–126|issn=1044579X|doi=10.1016/j.semcancer.2012.01.009}}</ref>


==Epidemiology==
===Region===
NPC is uncommon in the United States and most other nations, but is extremely common in Taiwan and certain regions of China, accounting for 18% of all cancers in the latter nation. While NPC is seen primarily in middle-aged persons in Asia, a high proportion of African cases appear in children. The cause of increased risk for NPC in these [[endemic (epidemiology)|endemic]] regions is not entirely clear.<ref name="Weidner's">{{cite book |author=Richard Cote, Saul Suster, Lawrence Weiss, Noel Weidner (Editor) |title=Modern Surgical Pathology (2 Volume Set) |publisher=W B Saunders |location=London |year= |pages= |isbn=0-7216-7253-1 |oclc= |doi=}}</ref>
*The majority of nasopharyngeal carcinoma cases are reported in southern China, Southeast Asia, North Africa and also is more seen in Inuit Indians.<ref name="ChangAdami2006">{{cite journal|last1=Chang|first1=E. T.|last2=Adami|first2=H.-O.|title=The Enigmatic Epidemiology of Nasopharyngeal Carcinoma|journal=Cancer Epidemiology Biomarkers & Prevention|volume=15|issue=10|year=2006|pages=1765–1777|issn=1055-9965|doi=10.1158/1055-9965.EPI-06-0353}}</ref><ref>{{Cite journal
| author = [[Muhyi Al-Sarraf]] & [[Maryada S. Reddy]]
| title = Nasopharyngeal carcinoma
| journal = [[Current treatment options in oncology]]
| volume = 3
| issue = 1
| pages = 21–32
| year = 2002
| month = February
| pmid = 12057084
}}</ref>


==References==
==References==
Line 13: Line 40:
{{WikiDoc Sources}}
{{WikiDoc Sources}}


[[Category:Disease]]
[[Category:Up-To-Date]]
 
[[Category:Medicine]]
[[Category:Types of cancer]]
[[Category:Oncology]]
[[Category:Oncology]]
[[Category:Otolaryngology]]

Latest revision as of 22:53, 29 July 2020

Nasopharyngeal carcinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Nasopharyngeal carcinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Nasopharyngeal carcinoma epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Nasopharyngeal carcinoma epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Nasopharyngeal carcinoma epidemiology and demographics

CDC on Nasopharyngeal carcinoma epidemiology and demographics

Nasopharyngeal carcinoma epidemiology and demographics in the news

Blogs on Nasopharyngeal carcinoma epidemiology and demographics

Directions to Hospitals Treating Nasopharyngeal carcinoma

Risk calculators and risk factors for Nasopharyngeal carcinoma epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2]Faizan Sheraz, M.D. [3]

Overview

The incidence of nasopharyngeal carcinoma is different based on the geographic areas. The incidence in the USA is low, in Alaska and Greenland is moderate and the highest incidence is seen in southeast Asia, North Africa, southern China and middle east. The incidence of this disease increases with increasing age in low- risk population. However, in high-risk populations, the maximum incidence is seen in individuals around ages 50 to 59 and then the incidence decreases by increasing age. Nasopharyngeal carcinoma usually affects individuals of the Asian race, and is more commonly affected by male than female. The majority of nasopharyngeal carcinoma cases are reported in southern China, Southeast Asia, North Africa and also is more seen in Inuit Indians.

Epidemiology and Demographics

Incidence

  • The incidence of nasopharyngeal carcinoma is different based on the geographic areas. The incidence in the USA is approximately 0.2 to 0.5 per 100,000 individuals, in Alaska and Greenland is 15 to 20 per 100,000 individuals and the highest incidence is seen in southeast Asia, North Africa, southern China and middle east with the incidence of 80 per 100,000 individuals.[1][2]

Case-fatality rate/Mortality rate

  • In 2008 , the incidence of nasopharyngeal carcinoma is approximately 0.84 per 100,000 individuals with mortality rate of 61.13%.[3]

Age

Race

  • Nasopharyngeal carcinoma usually affects individuals of the Asian race.[6]

Gender

Region

  • The majority of nasopharyngeal carcinoma cases are reported in southern China, Southeast Asia, North Africa and also is more seen in Inuit Indians.[8][9]

References

  1. ↑ Caponigro, Francesco; Longo, Francesco; Ionna, Franco; Perri, Francesco (2010). "Treatment approaches to nasopharyngeal carcinoma: a review". Anti-Cancer Drugs. 21 (5): 471–477. doi:10.1097/CAD.0b013e328337160e. ISSN 0959-4973.
  2. ↑ Lee, Anne W.M.; Ng, W.T.; Chan, Y.H.; Sze, Henry; Chan, Connie; Lam, T.H. (2012). "The battle against nasopharyngeal cancer". Radiotherapy and Oncology. 104 (3): 272–278. doi:10.1016/j.radonc.2012.08.001. ISSN 0167-8140.
  3. ↑ Jemal, Ahmedin; Bray, Freddie; Center, Melissa M.; Ferlay, Jacques; Ward, Elizabeth; Forman, David (2011). "Global cancer statistics". CA: A Cancer Journal for Clinicians. 61 (2): 69–90. doi:10.3322/caac.20107. ISSN 0007-9235.
  4. ↑ Lee, Jivianne T.; Ko, Clifford Y. (2016). "Has survival improved for nasopharyngeal carcinoma in the United States?". Otolaryngology-Head and Neck Surgery. 132 (2): 303–308. doi:10.1016/j.otohns.2004.09.018. ISSN 0194-5998.
  5. ↑ Lee, Anne W.M.; Foo, William; Mang, Oscar; Sze, W.M.; Chappell, Rick; Lau, W.H.; Ko, W.M. (2003). "Changing epidemiology of nasopharyngeal carcinoma in Hong Kong over a 20-year period (1980-99): An encouraging reduction in both incidence and mortality". International Journal of Cancer. 103 (5): 680–685. doi:10.1002/ijc.10894. ISSN 0020-7136.
  6. ↑ Wang, Yu; Zhang, Yawei; Ma, Shuangge (2013). "Racial differences in nasopharyngeal carcinoma in the United States". Cancer Epidemiology. 37 (6): 793–802. doi:10.1016/j.canep.2013.08.008. ISSN 1877-7821.
  7. ↑ Jia, Wei-Hua; Qin, Hai-De (2012). "Non-viral environmental risk factors for nasopharyngeal carcinoma: A systematic review". Seminars in Cancer Biology. 22 (2): 117–126. doi:10.1016/j.semcancer.2012.01.009. ISSN 1044-579X.
  8. ↑ Chang, E. T.; Adami, H.-O. (2006). "The Enigmatic Epidemiology of Nasopharyngeal Carcinoma". Cancer Epidemiology Biomarkers & Prevention. 15 (10): 1765–1777. doi:10.1158/1055-9965.EPI-06-0353. ISSN 1055-9965.
  9. ↑ Muhyi Al-Sarraf & Maryada S. Reddy (2002). "Nasopharyngeal carcinoma". Current treatment options in oncology. 3 (1): 21–32. PMID 12057084. Unknown parameter |month= ignored (help)


Template:WikiDoc Sources

Retrieved from "https://www.wikidoc.org/index.php?title=Nasopharyngeal_carcinoma_epidemiology_and_demographics&oldid=1641113"